INS and polycystic ovary syndrome: This supports the role of insulin in regulating AKR1C3 expression, leading to hyperandrogenemia, which in turn results in hyperinsulinemia and insulin resistance, creating a vicious cycle as discussed in the review by Storbeck and O’Reilly [47].